Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-09-13

FDA Approved: TAZAROTENE — Original Application (Cosette Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Cosette Pharmaceuticals' generic tazarotene through an Original Application (ANDA 215433). The product is intended for the treatment of acne vulgar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TAZAROTENE (TAZAROTENE)

Snippet

ORIG AP for TAZAROTENE (TAZAROTENE)